annual EBIT:
-$415.57M-$239.08M(-135.47%)Summary
- As of today (June 25, 2025), BEAM annual earnings before interest & taxes is -$415.57 million, with the most recent change of -$239.08 million (-135.47%) on December 31, 2024.
- During the last 3 years, BEAM annual EBIT has fallen by -$23.10 million (-5.89%).
- BEAM annual EBIT is now -452.96% below its all-time high of -$75.15 million, reached on December 31, 2019.
Performance
BEAM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$119.29M-$19.25M(-19.24%)Summary
- As of today (June 25, 2025), BEAM quarterly earnings before interest & taxes is -$119.29 million, with the most recent change of -$19.25 million (-19.24%) on March 31, 2025.
- Over the past year, BEAM quarterly EBIT has dropped by -$15.15 million (-14.55%).
- BEAM quarterly EBIT is now -189.78% below its all-time high of $132.86 million, reached on December 31, 2023.
Performance
BEAM quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$430.72M-$15.15M(-3.65%)Summary
- As of today (June 25, 2025), BEAM TTM earnings before interest & taxes is -$430.72 million, with the most recent change of -$15.15 million (-3.65%) on March 31, 2025.
- Over the past year, BEAM TTM EBIT has dropped by -$249.03 million (-137.07%).
- BEAM TTM EBIT is now -497.78% below its all-time high of -$72.05 million, reached on September 30, 2018.
Performance
BEAM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BEAM EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -135.5% | -14.6% | -137.1% |
3 y3 years | -5.9% | -56.5% | -60.5% |
5 y5 years | -453.0% | -320.7% | -376.5% |
BEAM EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -135.5% | at low | -189.8% | at low | -144.1% | at low |
5 y | 5-year | -453.0% | at low | -189.8% | +40.5% | -376.5% | at low |
alltime | all time | -453.0% | at low | -189.8% | +40.5% | -497.8% | at low |
BEAM EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$119.29M(+19.2%) | -$430.72M(+3.6%) |
Dec 2024 | -$415.57M(+135.5%) | -$100.04M(-6.1%) | -$415.57M(+127.5%) |
Sep 2024 | - | -$106.50M(+1.5%) | -$182.67M(-1.0%) |
Jun 2024 | - | -$104.89M(+0.7%) | -$184.44M(+1.5%) |
Mar 2024 | - | -$104.13M(-178.4%) | -$181.69M(+2.9%) |
Dec 2023 | -$176.49M(-47.9%) | $132.86M(-222.7%) | -$176.49M(-55.7%) |
Sep 2023 | - | -$108.27M(+6.0%) | -$398.33M(+4.4%) |
Jun 2023 | - | -$102.15M(+3.3%) | -$381.36M(+5.6%) |
Mar 2023 | - | -$98.93M(+11.2%) | -$361.18M(+6.7%) |
Dec 2022 | -$338.48M(-13.8%) | -$88.98M(-2.5%) | -$338.48M(+8.1%) |
Sep 2022 | - | -$91.30M(+11.4%) | -$312.98M(+7.4%) |
Jun 2022 | - | -$81.97M(+7.5%) | -$291.31M(+8.6%) |
Mar 2022 | - | -$76.22M(+20.1%) | -$268.32M(-31.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$392.46M(+195.6%) | -$63.48M(-8.8%) | -$392.46M(+6.1%) |
Sep 2021 | - | -$69.63M(+18.1%) | -$369.78M(+9.6%) |
Jun 2021 | - | -$58.97M(-70.6%) | -$337.47M(+10.7%) |
Mar 2021 | - | -$200.37M(+391.1%) | -$304.78M(+129.6%) |
Dec 2020 | -$132.76M(+76.7%) | -$40.80M(+9.3%) | -$132.76M(+12.2%) |
Sep 2020 | - | -$37.32M(+42.0%) | -$118.33M(+19.5%) |
Jun 2020 | - | -$26.29M(-7.3%) | -$99.03M(+9.6%) |
Mar 2020 | - | -$28.36M(+7.5%) | -$90.40M(+20.3%) |
Dec 2019 | -$75.15M(-35.6%) | -$26.37M(+46.3%) | -$75.15M(+1.6%) |
Sep 2019 | - | -$18.02M(+2.1%) | -$73.98M(-42.2%) |
Jun 2019 | - | -$17.65M(+34.7%) | -$128.01M(+16.0%) |
Mar 2019 | - | -$13.11M(-48.0%) | -$110.36M(+13.5%) |
Dec 2018 | -$116.74M | -$25.19M(-65.0%) | -$97.25M(+35.0%) |
Sep 2018 | - | -$72.05M | -$72.05M |
FAQ
- What is Beam Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Beam Therapeutics?
- What is Beam Therapeutics annual EBIT year-on-year change?
- What is Beam Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Beam Therapeutics?
- What is Beam Therapeutics quarterly EBIT year-on-year change?
- What is Beam Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Beam Therapeutics?
- What is Beam Therapeutics TTM EBIT year-on-year change?
What is Beam Therapeutics annual earnings before interest & taxes?
The current annual EBIT of BEAM is -$415.57M
What is the all time high annual EBIT for Beam Therapeutics?
Beam Therapeutics all-time high annual earnings before interest & taxes is -$75.15M
What is Beam Therapeutics annual EBIT year-on-year change?
Over the past year, BEAM annual earnings before interest & taxes has changed by -$239.08M (-135.47%)
What is Beam Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of BEAM is -$119.29M
What is the all time high quarterly EBIT for Beam Therapeutics?
Beam Therapeutics all-time high quarterly earnings before interest & taxes is $132.86M
What is Beam Therapeutics quarterly EBIT year-on-year change?
Over the past year, BEAM quarterly earnings before interest & taxes has changed by -$15.15M (-14.55%)
What is Beam Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of BEAM is -$430.72M
What is the all time high TTM EBIT for Beam Therapeutics?
Beam Therapeutics all-time high TTM earnings before interest & taxes is -$72.05M
What is Beam Therapeutics TTM EBIT year-on-year change?
Over the past year, BEAM TTM earnings before interest & taxes has changed by -$249.03M (-137.07%)